Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| RayzeBio, Inc. | 5,158,161 | 5,158,161 | 0 | 114,511 | 320,683 | 82.47% | +206,172 |
| CRISPR Therapeutics AG(CRSP) | 498,558 | 498,558 | 0 | 22,630 | 31,210 | 8.03% | +8,580 |
| Passage Bio, Inc.(PASG) | 4,959,769 | 4,959,769 | 0 | 3,264 | 5,009 | 1.29% | +1,746 |
| Gritstone Bio, Inc. | 3,561,150 | 3,561,150 | 0 | 6,125 | 7,265 | 1.87% | +1,140 |
| Aligos Therapeutics, Inc. | 2,320,381 | 2,320,381 | 0 | 1,733 | 1,541 | 0.40% | -193 |
| Minerva Surgical Inc. | 83,684 | 0 | -83,684 | 275 | 0 | — | -275 |
| Adverum Biotechnologies, Inc. | 5,068,233 | 5,068,233 | 0 | 7,602 | 3,815 | 0.98% | -3,787 |
| Repare Therapeutics, Inc. | 2,646,657 | 2,646,657 | 0 | 31,972 | 19,321 | 4.97% | -12,651 |